Moreover, they also demonstrated a decrease in CD133 marker expression after SIRT, which is found in EV-derived tumor progenitors and stem cells, implying the possible anti-tumor effect by modulating the release of EVs by the aforementioned parental cells. Here, PROM1 is linked to neoplasm.